W STRATEGIES, LLC

Lobbying for DYNE THERAPEUTICS, INC. · A biotechnology company developing nucleic acid therapies for rare diseases.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · $40,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Education about access to rare disease therapies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.